BDX vs. COO, HOLX, HSIC, AMN, CAH, DVA, MCK, TMO, ISRG, and BSX
Should you be buying Becton, Dickinson and Company stock or one of its competitors? The main competitors of Becton, Dickinson and Company include Cooper Companies (COO), Hologic (HOLX), Henry Schein (HSIC), AMN Healthcare Services (AMN), Cardinal Health (CAH), DaVita (DVA), McKesson (MCK), Thermo Fisher Scientific (TMO), Intuitive Surgical (ISRG), and Boston Scientific (BSX). These companies are all part of the "medical" sector.
Becton, Dickinson and Company vs. Its Competitors
Becton, Dickinson and Company (NYSE:BDX) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.
Becton, Dickinson and Company has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.
In the previous week, Becton, Dickinson and Company had 4 more articles in the media than Cooper Companies. MarketBeat recorded 28 mentions for Becton, Dickinson and Company and 24 mentions for Cooper Companies. Becton, Dickinson and Company's average media sentiment score of 0.97 beat Cooper Companies' score of 0.43 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.
87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by insiders. Comparatively, 2.0% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Becton, Dickinson and Company presently has a consensus price target of $219.22, suggesting a potential upside of 23.82%. Cooper Companies has a consensus price target of $99.70, suggesting a potential upside of 36.54%. Given Cooper Companies' stronger consensus rating and higher possible upside, analysts clearly believe Cooper Companies is more favorable than Becton, Dickinson and Company.
Becton, Dickinson and Company has higher revenue and earnings than Cooper Companies. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Cooper Companies has a net margin of 10.39% compared to Becton, Dickinson and Company's net margin of 7.28%. Becton, Dickinson and Company's return on equity of 15.99% beat Cooper Companies' return on equity.
Summary
Becton, Dickinson and Company and Cooper Companies tied by winning 8 of the 16 factors compared between the two stocks.
Get Becton, Dickinson and Company News Delivered to You Automatically
Sign up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Becton, Dickinson and Company Competitors List
Related Companies and Tools
This page (NYSE:BDX) was last updated on 7/3/2025 by MarketBeat.com Staff
